Current: English

Current Americas

We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More

Joseph Scheeren,PharmD

Member, Finance Committee

Senior Advisor R&DBayer AG

Dr. Scheeren started his pharmaceutical industry career in 1982 with Servier in Paris, responsible for Regulatory Affairs Northern and Eastern Europe, and Clinical Development in Munich from 1986 – 1987. In 1991, he was appointed Head of Worldwide Regulatory Affairs at Serono, Geneva. In 1992, he took over responsibility of the Global Regulatory Affairs department of Roussel UCLAF.

In 1996, he moved to New Jersey to head the Global Marketed Product Regulatory Affairs Department of Hoechst Marion Roussel.

Dr. Scheeren joined Bayer Pharmaceuticals as Senior Vice President, Head of Global Regulatory Affairs, in 2004, responsible for development in the US and in 2009 became Site Head US in Montville, NJ. In 2012, he assumed the position of Head of Global Development Asia in Beijing and in 2015, was appointed Head of Global Regulatory Affairs Pharma and Consumer Care of Bayer Healthcare, Basel. In January 2018, he was appointed Senior Advisor R&D, Bayer AG.

Dr. Scheeren holds many memberships and designations, serving on Advisory Boards at the Center for Innovation in Regulatory Science, SAFE-PHARMA, the Regulatory Affairs track at Yale University, the Center of Regulatory Excellence Singapore, the Research & Development-based Pharmaceutical Association in China, and the China Core Research and Development Committee. He has served as Chairman of the DIA Regional Advisory Council for Europe, Middle East & Africa; he is also a foreign member of the Academie Nationale de Pharmacie, France, and a lecturer at Yale University. Dr. Scheeren studied pharmacy at the University of Leiden.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.

DIA is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.